-
Sunovion Pharmaceuticals announces availability of Aptiom
MARLBOROUGH, Mass. — Sunovion Pharmaceuticals on Monday announced that Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug, is now available across the United States.
The drug, which received approval from the Food and Drug Administration on Nov. 8, 2013, is a prescription medicine used with other medicines to treat partial-onset seizures. The drug is available in four table strengths: 200 mg, 400 mg, 600 mg and 800 mg; it can be taken whole or crushed, with food or without.
-
Briggs Healthcare to make major push behind DME brand HealthSmart
WAUKEGAN, Ill. — Briggs Healthcare, a supplier to the hospital, pharmaceutical/DME and retail markets for 65 years, on Monday announced it is aligning its brands under the HealthSmart name as of summer 2014. The brand will be supported by a new website for wholesale and retail customers and, in collaboration with its retail partners, new packaging. Following the announcement, more than 1,000 products will be rebranded as HealthSmart.